80491-7850 : Quviviq 50 mg Oral Tablet, Film Coated
NDC: | 80491-7850 |
Labeler: | Idorsia Pharmaceuticals Ltd |
Product Type: | Human Prescription Drug |
Drug Name: | Quviviq |
Dosage Form: | Oral Tablet, Film Coated |
Application #: | NDA214985 |
Rev. Date: | |
CSA Schedule: | CIV (US) [1] |
[1] Schedule IV Controlled Substance: Low potential for abuse relative to substances in Schedule III. Examples include Alprazolam (Xanax), Diazepam (Valium), Carisoprodol (Soma), Clonazepam (Klonopin), Lorazepam (Ativan), Clorazepate (Tranxene), Midazolam (Versed), Temazepam (Restoril), and Triazolam (Halcion).. More Details: US Dept of Justice Controlled Substance Schedules.
NDC Package Codes:
- 80491-7850-2: 1 BLISTER PACK IN 1 CARTON (80491‑7850‑2) / 7 TABLET, FILM COATED IN 1 BLISTER PACK
- 80491-7850-3: 1 BOTTLE IN 1 CARTON (80491‑7850‑3) > 30 TABLET, FILM COATED IN 1 BOTTLE
Active Ingredients:
- Daridorexant
Dosage Strength:
- 50 mg
Pharmaceutical Classes:
- Orexin Receptor Antagonist [EPC]
- Orexin Receptor Antagonists [MoA]
Related Products:
Based on records with the same trade name.- 80491-7825 Quviviq 25 mg Oral Tablet, Film Coated by Idorsia Pharmaceuticals Ltd
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 80491-7825Next: 80499-001 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.